136 related articles for article (PubMed ID: 31149168)
1. THE PPARGC1A - GLY482SER POLYMORPHISM (RS8192678) AND THE METABOLIC SYNDROME IN A CENTRAL ROMANIAN POPULATION.
Csép K; Szigeti E; Vitai M; Korányi L
Acta Endocrinol (Buchar); 2017; 13(2):161-167. PubMed ID: 31149168
[TBL] [Abstract][Full Text] [Related]
2. The Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) is associated with type 2 diabetes in Tunisian population.
Jemaa Z; Kallel A; Sleimi C; Mahjoubi I; Feki M; Ftouhi B; Slimane H; Jemaa R; Kaabachi N
Diabetes Metab Syndr; 2015; 9(4):316-9. PubMed ID: 25470625
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
[TBL] [Abstract][Full Text] [Related]
4. Association between the PPARGC1A Gly482Ser polymorphism and muscle fitness in Chinese schoolchildren.
Wei Q
PLoS One; 2023; 18(4):e0284827. PubMed ID: 37104269
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis demonstrates Gly482Ser variant of PPARGC1A is associated with components of metabolic syndrome within Asian populations.
Bhatta P; Bermano G; Williams HC; Knott RM
Genomics; 2020 Mar; 112(2):1795-1803. PubMed ID: 31678594
[TBL] [Abstract][Full Text] [Related]
6.
Yvert T; Miyamoto-Mikami E; Tobina T; Shiose K; Kakigi R; Tsuzuki T; Takaragawa M; Ichinoseki-Sekine N; Pérez M; Kobayashi H; Tanaka H; Naito H; Fuku N
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32867330
[No Abstract] [Full Text] [Related]
7. Association of the Gly482Ser PPARGC1A gene variant with different cholesterol outcomes in response to two energy-restricted diets in subjects with excessive weight.
Ramos-Lopez O; Riezu-Boj JI; Milagro FI; Goni L; Cuervo M; Martinez JA
Nutrition; 2018 Mar; 47():83-89. PubMed ID: 29429541
[TBL] [Abstract][Full Text] [Related]
8. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L
Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
[TBL] [Abstract][Full Text] [Related]
9. [Association study between PPARGC1A Thr394Thr/ Gly482Ser polymorphisms and type 2 diabetes].
Su Y; Peng SB; Li ZQ; Huang QY
Yi Chuan; 2008 Mar; 30(3):304-8. PubMed ID: 18331997
[TBL] [Abstract][Full Text] [Related]
10. Association between PPARGC1A single nucleotide polymorphisms and increased risk of nonalcoholic fatty liver disease among Iranian patients with type 2 diabetes mellitus.
Saremi L; Lotfıpanah S; Mohammadi M; Hosseinzadeh H; Hosseini-Khah Z; Johari B; Saltanatpour Z
Turk J Med Sci; 2019 Aug; 49(4):1089-1094. PubMed ID: 31390852
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of obesity associated with the variant allele of the PPARGC1A Gly482Ser polymorphism in physically inactive elderly men.
Ridderstråle M; Johansson LE; Rastam L; Lindblad U
Diabetologia; 2006 Mar; 49(3):496-500. PubMed ID: 16474966
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the TFAM and PGC1-α genes and their association with polycystic ovary syndrome among South Indian women.
Reddy TV; Govatati S; Deenadayal M; Shivaji S; Bhanoori M
Gene; 2018 Jan; 641():129-136. PubMed ID: 29030253
[TBL] [Abstract][Full Text] [Related]
13. Association of Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1 Alpha Coding Variants with Hepatocellular Carcinoma Risk in the Moroccan Population: A Case-Control Study.
Tanouti IA; Fellah H; El Fihry R; Zerrad C; Abounouh K; Tahiri M; Belkouchi A; Badre W; Pineau P; Benjelloun S; Ezzikouri S
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3689-3696. PubMed ID: 38019226
[TBL] [Abstract][Full Text] [Related]
14. Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
Tai CM; Huang CK; Tu HP; Hwang JC; Yeh ML; Huang CF; Huang JF; Dai CY; Chuang WL; Yu ML
Medicine (Baltimore); 2016 Mar; 95(12):e3120. PubMed ID: 27015186
[TBL] [Abstract][Full Text] [Related]
15. Correlation Between
Du F; Yang KJ; Piao LS
Open Life Sci; 2019 Jan; 14():43-52. PubMed ID: 33817136
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes.
Barroso I; Luan J; Sandhu MS; Franks PW; Crowley V; Schafer AJ; O'Rahilly S; Wareham NJ
Diabetologia; 2006 Mar; 49(3):501-5. PubMed ID: 16435105
[TBL] [Abstract][Full Text] [Related]
17. Is there an interaction between PPARD T294C and PPARGC1A Gly482Ser polymorphisms and human endurance performance?
Eynon N; Meckel Y; Alves AJ; Yamin C; Sagiv M; Goldhammer E; Sagiv M
Exp Physiol; 2009 Nov; 94(11):1147-52. PubMed ID: 19666693
[TBL] [Abstract][Full Text] [Related]
18. Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome.
Ambye L; Rasmussen S; Fenger M; Jørgensen T; Borch-Johnsen K; Madsbad S; Urhammer SA
Diabetes Res Clin Pract; 2005 Feb; 67(2):175-9. PubMed ID: 15649578
[TBL] [Abstract][Full Text] [Related]
19. Association and interaction analysis of PPARGC1A and serum uric acid on type 2 diabetes mellitus in Chinese Han population.
Wu HH; Liu NJ; Yang Z; Tao XM; Du YP; Wang XC; Lu B; Zhang ZY; Hu RM; Wen J
Diabetol Metab Syndr; 2014; 6(1):107. PubMed ID: 25302081
[TBL] [Abstract][Full Text] [Related]
20. Impact of the PPARGC1A Gly482Ser polymorphism on left ventricular structural and functional abnormalities in patients with hypertension.
Rojek A; Cielecka-Prynda M; Przewlocka-Kosmala M; Laczmanski L; Mysiak A; Kosmala W
J Hum Hypertens; 2014 Sep; 28(9):557-63. PubMed ID: 24718382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
